Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of (Q42556536)
Jump to navigation
Jump to search
scientific article published on April 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of |
scientific article published on April 1996 |
Statements
1 reference
Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of (English)
1 reference
T S Lin
1 reference
M Z Luo
1 reference
M C Liu
1 reference
Y L Zhu
1 reference
E Gullen
1 reference
G E Dutschman
1 reference
Y C Cheng
1 reference
1 April 1996
1 reference
1 reference
Identifiers
1 reference